| inflammatory response | GO:0006954 | 244 | 0.432 | |
| angiogenesis | GO:0001525 | 201 | 0.372 | |
| developmental maturation | GO:0021700 | 193 | 0.333 | |
| circulatory system process | GO:0003013 | 197 | 0.328 | |
| blood circulation | GO:0008015 | 195 | 0.288 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.247 | |
| oxidation reduction process | GO:0055114 | 342 | 0.246 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.216 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.208 | |
| skin development | GO:0043588 | 220 | 0.201 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.194 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.190 | |
| regulation of defense response | GO:0031347 | 233 | 0.188 | |
| lipid transport | GO:0006869 | 98 | 0.185 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.185 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.178 | |
| muscle system process | GO:0003012 | 141 | 0.169 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.169 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.169 | |
| embryonic placenta development | GO:0001892 | 98 | 0.165 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.156 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.148 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.145 | |
| skeletal system development | GO:0001501 | 356 | 0.144 | |
| action potential | GO:0001508 | 78 | 0.141 | |
| response to nutrient levels | GO:0031667 | 109 | 0.141 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.141 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.140 | |
| regulation of system process | GO:0044057 | 200 | 0.138 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.137 | |
| amine metabolic process | GO:0009308 | 45 | 0.136 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.133 | |
| placenta development | GO:0001890 | 140 | 0.131 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.128 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.127 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.127 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.126 | |
| cation transport | GO:0006812 | 399 | 0.125 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.123 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.120 | |
| digestion | GO:0007586 | 40 | 0.119 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.118 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.117 | |
| regionalization | GO:0003002 | 337 | 0.116 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.116 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.113 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.113 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.113 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.111 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.111 | |
| visual perception | GO:0007601 | 52 | 0.111 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.110 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.110 | |
| cellular homeostasis | GO:0019725 | 240 | 0.109 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.109 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.106 | |
| somatotropin secreting cell development | GO:0060133 | 2 | 0.105 | |
| ovulation cycle | GO:0042698 | 59 | 0.105 | |
| regulation of secretion | GO:0051046 | 274 | 0.102 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.101 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.100 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.100 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.099 | |
| cell maturation | GO:0048469 | 127 | 0.098 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.096 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.096 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.094 | |
| segmentation | GO:0035282 | 93 | 0.093 | |
| gland development | GO:0048732 | 330 | 0.093 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.091 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.089 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.089 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.089 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.085 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.085 | |
| striated muscle cell development | GO:0055002 | 125 | 0.085 | |
| mitral valve development | GO:0003174 | 4 | 0.084 | |
| lipid localization | GO:0010876 | 126 | 0.083 | |
| diencephalon development | GO:0021536 | 63 | 0.083 | |
| regulation of ossification | GO:0030278 | 112 | 0.082 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.082 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.080 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.080 | |
| semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:0071527 | 1 | 0.080 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.079 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.078 | |
| muscle tissue development | GO:0060537 | 308 | 0.078 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.078 | |
| cardiac chamber development | GO:0003205 | 108 | 0.077 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.077 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.077 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.076 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.076 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.076 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.076 | |
| forebrain development | GO:0030900 | 302 | 0.075 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.074 | |
| protein catabolic process | GO:0030163 | 221 | 0.074 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.074 | |
| rhythmic process | GO:0048511 | 174 | 0.074 | |
| cytokine production | GO:0001816 | 319 | 0.074 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.074 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.073 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.073 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.073 | |
| connective tissue development | GO:0061448 | 179 | 0.073 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.072 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.072 | |
| heart morphogenesis | GO:0003007 | 178 | 0.072 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.072 | |
| extracellular structure organization | GO:0043062 | 148 | 0.072 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.071 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.071 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.071 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.070 | |
| steroid metabolic process | GO:0008202 | 119 | 0.070 | |
| neuronal action potential | GO:0019228 | 54 | 0.070 | |
| hormone metabolic process | GO:0042445 | 86 | 0.070 | |
| transmembrane transport | GO:0055085 | 412 | 0.069 | |
| cellular response to lipid | GO:0071396 | 145 | 0.069 | |
| tendon formation | GO:0035992 | 4 | 0.068 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.068 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.068 | |
| epidermis development | GO:0008544 | 187 | 0.068 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.067 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.067 | |
| tissue remodeling | GO:0048771 | 102 | 0.067 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.066 | |
| somite development | GO:0061053 | 81 | 0.066 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.066 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.065 | |
| locomotory behavior | GO:0007626 | 195 | 0.064 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.064 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.063 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.063 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.063 | |
| multicellular organism growth | GO:0035264 | 161 | 0.063 | |
| protein ubiquitination | GO:0016567 | 171 | 0.062 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.062 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.062 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.061 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.061 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.061 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.061 | |
| tube formation | GO:0035148 | 140 | 0.061 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.061 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.060 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.060 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.060 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.059 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.058 | |
| cartilage development | GO:0051216 | 140 | 0.058 | |
| ear development | GO:0043583 | 200 | 0.058 | |
| gliogenesis | GO:0042063 | 141 | 0.057 | Mouse |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.057 | |
| camera type eye development | GO:0043010 | 266 | 0.056 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.056 | |
| positive regulation of inner ear receptor cell differentiation | GO:2000982 | 1 | 0.056 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.056 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.055 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.054 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.053 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.053 | |
| sensory perception | GO:0007600 | 245 | 0.053 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.052 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.052 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.052 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.052 | |
| embryonic heart tube formation | GO:0003144 | 1 | 0.052 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.051 | |
| positive regulation of auditory receptor cell differentiation | GO:0045609 | 1 | 0.051 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.051 | |
| regulation of tube size | GO:0035150 | 57 | 0.050 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.050 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.050 | |
| endocrine system development | GO:0035270 | 98 | 0.049 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.049 | |
| axonogenesis | GO:0007409 | 274 | 0.049 | Mouse |
| organ growth | GO:0035265 | 117 | 0.049 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.048 | |
| ossification | GO:0001503 | 216 | 0.048 | |
| urogenital system development | GO:0001655 | 261 | 0.048 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.048 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.048 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.048 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.048 | |
| nerve development | GO:0021675 | 67 | 0.048 | |
| camp biosynthetic process | GO:0006171 | 31 | 0.048 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.047 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.047 | |
| generation of ovulation cycle rhythm | GO:0060112 | 1 | 0.047 | |
| bone mineralization | GO:0030282 | 54 | 0.047 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.047 | |
| positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:2000764 | 1 | 0.046 | |
| auditory receptor cell fate determination | GO:0042668 | 3 | 0.046 | |
| cell adhesion | GO:0007155 | 329 | 0.046 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 26 | 0.046 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.046 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.046 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.046 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.046 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.046 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.045 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.045 | |
| ectoderm formation | GO:0001705 | 3 | 0.045 | |
| hindbrain development | GO:0030902 | 128 | 0.044 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.044 | |
| neural retina development | GO:0003407 | 41 | 0.044 | |
| female sex differentiation | GO:0046660 | 84 | 0.044 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.044 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.044 | |
| exocytosis | GO:0006887 | 121 | 0.044 | |
| regulation of cell motility | GO:2000145 | 236 | 0.044 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.043 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.043 | |
| chondrocyte development | GO:0002063 | 24 | 0.043 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.043 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.043 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.043 | |
| organelle localization | GO:0051640 | 179 | 0.043 | |
| intracellular distribution of mitochondria | GO:0048312 | 1 | 0.042 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.042 | |
| appendage development | GO:0048736 | 166 | 0.042 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.042 | |
| somitogenesis | GO:0001756 | 69 | 0.042 | |
| cell proliferation involved in heart valve development | GO:2000793 | 2 | 0.042 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.041 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.041 | |
| muscle contraction | GO:0006936 | 101 | 0.041 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.041 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.041 | |
| myelination | GO:0042552 | 74 | 0.041 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.040 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.040 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 26 | 0.040 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.040 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.040 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.040 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.040 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.040 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.040 | |
| axon ensheathment | GO:0008366 | 76 | 0.040 | |
| oviduct development | GO:0060066 | 3 | 0.039 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.039 | |
| response to peptide | GO:1901652 | 136 | 0.039 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.039 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.039 | |
| positive regulation of cyclic nucleotide metabolic process | GO:0030801 | 24 | 0.039 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.038 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.038 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.038 | |
| mesonephros development | GO:0001823 | 97 | 0.038 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.038 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.037 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.037 | |
| response to light stimulus | GO:0009416 | 135 | 0.037 | |
| cation homeostasis | GO:0055080 | 212 | 0.037 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.037 | |
| renal system development | GO:0072001 | 225 | 0.037 | |
| circadian rhythm | GO:0007623 | 114 | 0.037 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.037 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.037 | |
| response to inorganic substance | GO:0010035 | 96 | 0.037 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.037 | |
| norepinephrine transport | GO:0015874 | 2 | 0.036 | |
| fertilization | GO:0009566 | 127 | 0.036 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.036 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.036 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.036 | |
| calcium ion transport | GO:0006816 | 159 | 0.036 | |
| nephron epithelium development | GO:0072009 | 92 | 0.036 | |
| compound eye development | GO:0048749 | 1 | 0.036 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.035 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.035 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.035 | |
| positive regulation of the force of heart contraction by chemical signal | GO:0003099 | 3 | 0.035 | |
| biomineral tissue development | GO:0031214 | 64 | 0.035 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.035 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.035 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.035 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.035 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.035 | |
| intermediate filament cytoskeleton organization | GO:0045104 | 26 | 0.035 | |
| mitochondrion distribution | GO:0048311 | 4 | 0.034 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.034 | |
| respiratory tube development | GO:0030323 | 167 | 0.034 | |
| positive regulation of camp metabolic process | GO:0030816 | 19 | 0.034 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 34 | 0.034 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.034 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.034 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.034 | |
| regulation of oxidative phosphorylation uncoupler activity | GO:2000275 | 3 | 0.034 | |
| activation of transmembrane receptor protein tyrosine kinase activity | GO:0007171 | 3 | 0.034 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.033 | |
| positive regulation of purine nucleotide biosynthetic process | GO:1900373 | 26 | 0.033 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.033 | |
| transdifferentiation | GO:0060290 | 1 | 0.033 | |
| limb morphogenesis | GO:0035108 | 149 | 0.033 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.033 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.033 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.033 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.033 | |
| ear morphogenesis | GO:0042471 | 118 | 0.033 | |
| neural tube development | GO:0021915 | 160 | 0.032 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.032 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.032 | |
| female gonad development | GO:0008585 | 71 | 0.032 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.032 | |
| stem cell differentiation | GO:0048863 | 268 | 0.032 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.032 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.032 | |
| artery development | GO:0060840 | 53 | 0.032 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.032 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.031 | |
| water homeostasis | GO:0030104 | 27 | 0.031 | |
| protein maturation | GO:0051604 | 176 | 0.031 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.031 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.031 | |
| negative regulation of type b pancreatic cell apoptotic process | GO:2000675 | 3 | 0.031 | |
| response to growth factor | GO:0070848 | 198 | 0.031 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.031 | |
| regulation of digestive system process | GO:0044058 | 13 | 0.031 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.031 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.031 | |
| adult behavior | GO:0030534 | 135 | 0.031 | |
| muscle cell development | GO:0055001 | 133 | 0.031 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.031 | |
| stem cell development | GO:0048864 | 219 | 0.030 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.030 | |
| positive regulation of mechanoreceptor differentiation | GO:0045633 | 1 | 0.030 | |
| regulation of epidermis development | GO:0045682 | 33 | 0.030 | |
| stem cell maintenance | GO:0019827 | 130 | 0.030 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.030 | |
| cranial nerve development | GO:0021545 | 41 | 0.030 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.030 | |
| general adaptation syndrome | GO:0051866 | 2 | 0.030 | |
| ureteric bud development | GO:0001657 | 94 | 0.030 | |
| associative learning | GO:0008306 | 61 | 0.030 | |
| detection of abiotic stimulus | GO:0009582 | 60 | 0.030 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.030 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.030 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.030 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.030 | |
| sclerotome development | GO:0061056 | 4 | 0.030 | |
| gonad development | GO:0008406 | 141 | 0.030 | |
| negative regulation of camp mediated signaling | GO:0043951 | 3 | 0.029 | |
| renal capsule specification | GO:0072130 | 1 | 0.029 | |
| bone development | GO:0060348 | 120 | 0.029 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.029 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.029 | |
| telencephalon development | GO:0021537 | 186 | 0.029 | |
| body fluid secretion | GO:0007589 | 53 | 0.029 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.029 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.029 | |
| heart process | GO:0003015 | 94 | 0.029 | |
| cardiac right ventricle formation | GO:0003219 | 3 | 0.029 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.029 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.029 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.029 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.028 | |
| positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway | GO:0010579 | 3 | 0.028 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.028 | |
| hemangioblast cell differentiation | GO:0060217 | 1 | 0.028 | |
| nephron development | GO:0072006 | 109 | 0.028 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.028 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.028 | |
| kidney epithelium development | GO:0072073 | 121 | 0.028 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.028 | |
| tendon cell differentiation | GO:0035990 | 4 | 0.028 | |
| cervix development | GO:0060067 | 2 | 0.028 | |
| regulation of mast cell differentiation | GO:0060375 | 3 | 0.028 | |
| endocytosis | GO:0006897 | 168 | 0.028 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.028 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.027 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.027 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.027 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.027 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.027 | |
| intermediate filament organization | GO:0045109 | 15 | 0.027 | |
| tissue homeostasis | GO:0001894 | 115 | 0.027 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.027 | |
| regulation of protein localization | GO:0032880 | 231 | 0.027 | |
| blastocyst development | GO:0001824 | 80 | 0.026 | |
| glucose homeostasis | GO:0042593 | 128 | 0.026 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.026 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.026 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.026 | |
| response to metal ion | GO:0010038 | 47 | 0.026 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.026 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.026 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.026 | |
| wound healing | GO:0042060 | 157 | 0.026 | |
| regulation of camp biosynthetic process | GO:0030817 | 25 | 0.025 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.025 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.025 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.025 | |
| general adaptation syndrome behavioral process | GO:0051867 | 1 | 0.025 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.025 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.025 | |
| intermediate filament based process | GO:0045103 | 27 | 0.025 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.025 | |
| cell fate determination | GO:0001709 | 32 | 0.025 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.025 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.025 | |
| negative regulation of growth | GO:0045926 | 99 | 0.025 | |
| glycogen metabolic process | GO:0005977 | 32 | 0.025 | |
| corticosterone secretion | GO:0035934 | 3 | 0.025 | |
| cell proliferation in forebrain | GO:0021846 | 30 | 0.025 | |
| conditioned taste aversion | GO:0001661 | 4 | 0.025 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.025 | |
| negative regulation of synapse maturation | GO:2000297 | 2 | 0.025 | |
| forebrain neuron development | GO:0021884 | 30 | 0.025 | |
| negative regulation of oxidative phosphorylation uncoupler activity | GO:2000276 | 2 | 0.025 | |
| positive regulation of synaptic plasticity | GO:0031915 | 4 | 0.025 | |
| molting cycle | GO:0042303 | 90 | 0.024 | |
| synapse organization | GO:0050808 | 125 | 0.024 | |
| cognition | GO:0050890 | 149 | 0.024 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.024 | |
| secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | GO:0060528 | 4 | 0.024 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.024 | |
| regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway | GO:0010578 | 3 | 0.024 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.024 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.024 | |
| neuron projection guidance | GO:0097485 | 141 | 0.024 | Mouse |
| renal tubule development | GO:0061326 | 87 | 0.024 | |
| chromatin modification | GO:0016568 | 187 | 0.024 | |
| synaptic transmission | GO:0007268 | 329 | 0.024 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.024 | |
| lung development | GO:0030324 | 164 | 0.024 | |
| acetate ester transport | GO:1901374 | 2 | 0.024 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.024 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.024 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.024 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.024 | |
| dendrite development | GO:0016358 | 115 | 0.023 | Mouse |
| response to acid chemical | GO:0001101 | 111 | 0.023 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.023 | |
| bone resorption | GO:0045453 | 38 | 0.023 | |
| regulation of binding | GO:0051098 | 111 | 0.023 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 34 | 0.023 | |
| protein processing | GO:0016485 | 163 | 0.023 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.023 | |
| gastrulation | GO:0007369 | 116 | 0.023 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.023 | |
| lipid catabolic process | GO:0016042 | 69 | 0.023 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.023 | |
| histamine induced gastric acid secretion | GO:0001697 | 1 | 0.023 | |
| odontogenesis | GO:0042476 | 78 | 0.023 | |
| chromatin organization | GO:0006325 | 206 | 0.023 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.022 | |
| metencephalon development | GO:0022037 | 89 | 0.022 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.022 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.022 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.022 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.022 | |
| muscle adaptation | GO:0043500 | 39 | 0.022 | |
| response to oxygen levels | GO:0070482 | 62 | 0.022 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.022 | |
| sensory system development | GO:0048880 | 3 | 0.022 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.022 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.022 | |
| histone modification | GO:0016570 | 159 | 0.022 | |
| endomembrane system organization | GO:0010256 | 147 | 0.022 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.022 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.022 | |
| collagen fibril organization | GO:0030199 | 32 | 0.022 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.021 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.021 | |
| camp metabolic process | GO:0046058 | 40 | 0.021 | |
| regulation of retina development in camera type eye | GO:1902866 | 3 | 0.021 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.021 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.021 | |
| interleukin 8 production | GO:0032637 | 4 | 0.021 | |
| positive regulation of growth hormone secretion | GO:0060124 | 3 | 0.021 | |
| chemotaxis | GO:0006935 | 247 | 0.021 | Mouse |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.021 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.021 | |
| muscle fiber development | GO:0048747 | 76 | 0.021 | |
| vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure | GO:0002025 | 3 | 0.021 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.021 | |
| negative regulation of peroxisome proliferator activated receptor signaling pathway | GO:0035359 | 3 | 0.021 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.021 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.021 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.021 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.021 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.021 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.020 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.020 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.020 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.020 | |
| mesenchyme development | GO:0060485 | 152 | 0.020 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.020 | |
| acetylcholine secretion neurotransmission | GO:0014055 | 2 | 0.020 | |
